Quantcast

Latest ESRD Stories

2014-05-15 08:32:20

Study will evaluate tenapanor for the treatment of hyperphosphatemia in ESRD patients on hemodialysis FREMONT, Calif., May 15, 2014 /PRNewswire/ -- Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, GI and metabolic diseases, today announced that it has received a $25 million milestone payment from AstraZeneca (NYSE:AZN, LON:AZN) for the initiation of a Phase 2b clinical trial evaluating tenapanor for the treatment of hyperphosphatemia, or elevated...

2014-04-24 12:28:46

LAS VEGAS, April 24, 2014 /PRNewswire/ -- On Wednesday, April 23, 2014, Affiliated Dialysis Centers, LLC ("ADC") shared the release of clinical data in a Late Breaking Poster Session at the 2014 National Kidney Foundation (NKF) Spring Clinical Meetings in Las Vegas, NV. Xelay Acumen, a strategy and medical data analytics firm, independently led the data collection and analysis effort, and Dr. Alex Yang, M.D. presented the results. Earlier this year, ADC presented the first results of a large...

2014-03-20 12:29:52

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022 EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2022SummaryChronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and leads to the loss of kidney function over time. CKD affects people of all ages; however, the risk is higher in...

2014-02-19 12:28:30

ATLANTA, Feb. 19, 2014 /PRNewswire/ -- On Monday, February 10, 2014, Affiliated Dialysis Centers, LLC ("ADC") shared its first release of clinical data at the 2014 34(th) Annual Dialysis Conference in Atlanta, GA. Since 2013, ADC has engaged Xelay Acumen, a strategy and medical data analytics firm, to independently lead its data collection and analysis effort. Dr. Alex Yang MD presented the initial results from this health outcomes clinical research study involving ESRD patients who...

2014-02-06 16:27:53

Leading home dialysis company announces new patient outreach campaign aimed at increasing awareness of home hemodialysis among ESRD patients ATLANTA, Feb. 6, 2014 /PRNewswire/ -- NxStage Medical Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced from the Annual Dialysis Conference (ADC) in Atlanta, Georgia (booth #411) the introduction of a new patient outreach campaign, NxStage Plus One. This campaign aims to increase awareness of home...

2013-09-10 23:27:21

Approval of This Novel Phosphate Binder Will Be a Major Milestone for the Company Cary, NC (PRWEB) September 10, 2013 BioLink Life Sciences, Inc., a biopharmaceutical innovator, announced today that the U.S. Food & Drug Administration (FDA) has accepted its New Drug Application for PiLo™ (calcium succinate capsules) for review. PiLo™ is the Company's patented phosphate binder for the treatment of elevated blood phosphate in patients with end stage renal disease (ESRD). Upon...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related